HAJTI GROUP is a deep-tech company developing AI-powered clinical intelligence to transform fragmented healthcare information into actionable insights at the point of decision.
Through NurAxis AI and our flagship product, Dr. Axis, we are building the foundations for more connected clinical workflows and more accessible decision support.
Healthcare professionals operate in information-intensive environments where decisions depend on multiple sources of clinical information, medical references, calculations, protocols, and documentation.
Yet these resources are often fragmented across disconnected tools and workflows.
At HAJTI GROUP, we see an opportunity to build technology that brings relevant information closer to the point of decision, helping clinicians navigate complexity with greater clarity and efficiency.
Critical clinical information is distributed across multiple resources, requiring professionals to navigate between tools and references.
Clinical calculations, medication considerations, protocols, and documentation can create additional demands within already time-sensitive environments.
Clinical knowledge becomes more useful when relevant capabilities and information are accessible within connected workflows.
Dr. Axis
Dr. Axis is our flagship clinical intelligence product, designed to bring essential clinical support capabilities into a connected environment.
By combining clinical calculations, protocols and guidelines, pharmacology, antibiotic suggestions, and collaboration capabilities, Dr. Axis aims to reduce information fragmentation and make clinical support tools more accessible within professional workflows.
Built around the needs of healthcare professionals, Dr. Axis continues to evolve through product development, user feedback, and clinical evaluation.
It is designed to help healthcare professionals access clinical tools, references, and collaborative capabilities without treating each task as an isolated workflow.
Tools designed to support clinical scores, calculations, and related clinical tasks.
Access to relevant clinical reference material to support professional assessment and decision-making.
Medication-related information and clinical considerations accessible within the application.
Decision-support capabilities intended to assist clinicians in evaluating antibiotic options.
Suggestions do not replace clinical assessment, applicable protocols, or professional prescribing responsibility.
Capabilities designed to facilitate the sharing of relevant information within supported workflows.
Features designed to support professional communication and collaboration.
Dr. Axis is evolving through product development, feedback, and evaluation. Capabilities still in progress should not be interpreted as generally available features.
Our approach combines product development with direct engagement from healthcare professionals and structured performance evaluation.
Physicians
Physicians in the reported Dr. Axis user cohort.
Prospective users
Individuals on the reported waiting list.
Released and validated features
Clinical Calculations, Protocols and Guidelines, Pharmacology, Antibiotic Suggestions, Share, and Collaboration.
Usability score
System Usability Scale score reported in the clinical performance evaluation.
Benchmark: average SUS score of 68 across 500 studies (Sauro, 2011).
These milestones reflect our progress toward building and evaluating practical clinical technology. We continue to work toward broader validation, scalability, and institutional integration. Figures are as reported by HAJTI GROUP; the usability score comes from a retrospective evaluation and does not establish clinical effectiveness or patient outcomes.
Six features currently identified as released and validated: Clinical Calculations, Protocols and Guidelines, Pharmacology, Antibiotic Suggestions, Share, and Collaboration.
Medical prescription generation is progressing through validation. Imaging analysis and insurance-related capabilities remain under development.
Our longer-term priorities include further clinical evaluation, improved scalability, and exploring appropriate integration into institutional workflows.
The availability, validation status, and intended use of individual capabilities may differ. The roadmap is subject to change as development and evaluation progress.
NurAxis AI
NurAxis AI represents HAJTI GROUP’s broader ambition to develop connected AI capabilities for healthcare.
Our technology direction focuses on transforming fragmented information into structured, contextual, and actionable support that can fit within professional workflows.
Our longer-term ambition is to build a scalable foundation for clinical intelligence, informed by practical requirements, product experience, and the evolving needs of healthcare professionals and institutions.
Technology and innovation
Clinical intelligence requires more than access to information. It requires technology that can make relevant information accessible, support specific tasks, and fit into the environments where professionals work.
Making relevant information and capabilities accessible in relation to the task being performed.
Bringing complementary clinical support capabilities into a more coherent user experience.
Designing decision-support capabilities around professional responsibility and clinical judgment.
Developing products and technical foundations that can evolve as user needs and deployment requirements grow.
Using structured feedback and evaluation to identify limitations and guide continued development.
About HAJTI GROUP
HAJTI GROUP develops technology designed to address complex, information-intensive challenges through artificial intelligence, software engineering, and applied innovation.
Our work starts with practical problems. We seek to understand the environments in which professionals operate, identify where technology can create meaningful value, and develop solutions that evolve through real-world use, structured evaluation, and continuous improvement.
Our current focus is healthcare, where fragmented information and demanding clinical workflows create a compelling need for more connected and accessible decision-support tools.
The company driving our strategy, product development, and long-term technology ambition.
Our broader AI technology platform and vision for connected, intelligent healthcare workflows.
Our flagship clinical intelligence product, designed to support healthcare professionals through accessible clinical tools and decision-support capabilities.
Together, these elements connect our company vision with a focused product and a broader technology direction.
We build technology around real problems and professional needs, prioritizing useful capabilities over novelty alone.
We approach AI as a means of supporting human expertise. In clinical contexts, professional judgment and appropriate oversight remain central.
We use feedback, structured evaluation, and ongoing development to understand product performance, identify limitations, and guide improvements.
We aim to make relevant information and capabilities more accessible within the workflows where they are needed.
We develop products with attention to technical scalability, commercial sustainability, and the evolving needs of the environments we serve.
To develop AI-powered clinical intelligence that transforms fragmented information into useful, accessible support for healthcare professionals at the point of decision.
To build a scalable technology foundation for connected clinical intelligence, bringing information, decision-support capabilities, and workflows closer together.
We focus on practical utility rather than technology for its own sake. Our products are developed around real operational needs, with attention to usability, validation, responsible AI, and the role of professional judgment.
Our work brings together business leadership, software engineering, artificial intelligence, and clinical expertise.
Co-founder and CEO
Hammadi Kadri leads HAJTI GROUP’s strategy, business development, and company growth.
With a background in banking and consulting, he brings experience in financial analysis, strategic thinking, and business development to the company’s mission of building practical, scalable technology.
His focus is on translating technical innovation into viable products, developing strategic relationships, and positioning HAJTI GROUP for international growth.
Clinical expertise
Name, biography and photograph to be added.
We believe meaningful clinical technology requires more than technical capability alone. It requires an understanding of professional workflows, real-world constraints, and the responsibilities associated with decision-support tools.
HAJTI GROUP’s development reflects an ongoing process of product evolution, clinical engagement, and international development.
We continue to develop the product, strengthen our evidence base, and explore opportunities for institutional collaboration and broader adoption.
Insights
From clinical performance evaluation and product development to the evolution of AI-powered decision support, our insights document what we are building, what we are learning, and how we approach the challenges of clinical intelligence.
An overview of the retrospective evaluation, including its scope, reported findings, and limitations, distinguishing measured evaluation results from established clinical outcomes.
We welcome conversations with healthcare professionals, healthcare institutions, research organizations, technology partners, and investors interested in our work.
For hospitals, healthcare providers, and clinical teams interested in product demonstrations, evaluation opportunities, or potential institutional collaboration.
Discuss an institutional collaborationFor researchers, technology providers, and organizations interested in applied AI, technical collaboration, research initiatives, or innovation programs.
Discuss a research or technology partnershipFor investors and commercial partners interested in HAJTI GROUP’s strategy, product development, and growth opportunities.
Contact our business teamPlease provide a few details so that we can direct your inquiry to the appropriate person.
We look forward to learning more about your work and exploring whether there is an opportunity to collaborate.
